The White House announced on the 23rd that it would invest in a cancer vaccine development project using messenger ribonucleic acid (mRNA) technology, which made significant progress in the development of a novel coronavirus infection (Corona 19) vaccine.
“Cancer Moonshot,” President Joe Biden’s cancer conquest project, said in a press release on the same day, “Investing $24 million in Emory University’s ‘CUREIT’, which uses mRNA technology to combat cancer and other diseases.”
mRNA, which serves as a kind of blueprint that tells the body how to make proteins, is a substance that has begun to receive attention in earnest after the COVID-19 crisis. A vaccine based on this injects mRNA containing viral information into the body to synthesize viral proteins on its own, inducing antibody formation accordingly. After the Corona 19 pandemic is over, it is expanding its scope to other diseases such as colds and cancer.
The White House explained, “The goal of Curate is to create mRNA that promotes the formation of immune cells that can target and attack tumours.”
President Biden said, “We launched the ‘Cancer Moonshot’ project to end cancer,” and “Today we took an important step toward this goal. We will use mRNA technology to develop technology to boost our immune system to fight cancer. that,” he emphasized. “The Emory research team is using the mRNA technology that has been used to end the coronavirus crisis for years, turning cancer into a more treatable disease,” he added.
The ‘Cancer Moonshot’ project, named after mankind’s moonshot, is a large-scale project that encompasses the development of innovative technologies at the federal government level to overcome cancer, as well as cancer prevention and expansion of medical convenience in the community. Earlier, at the Korea-US-Japan summit held at Camp David on the 18th, President Biden said, “We decided to support the US cancer conquest project ‘Cancer Moonshot’ through exchanges of experts from the three countries.”